Read More 2 minute read Biotech General Health Care Large Cap Movers News AstraZeneca’s Reinforces Hold In Lung Cancer Settings: Touts Promising Data From Three Trials By Vandana Singh September 11, 9:59 AM Daiichi Sankyo (OTC: DSKYF) (OTC: DSNKY) and AstraZeneca plc (NASDAQ: AZN) released initial results from the TROPION-Lung04 phase 1b tria AZN
Read More 1 minute read Biotech Contracts General Health Care News Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis’ Sandoz Inks Pact With Samsung Bioepis By Vandana Singh September 11, 9:32 AM Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has ABBV
Read More 2 minute read General Health Care Legal News How A Small Indian Firm Firm Was Pulled Into A Legal Battle with Big Pharma Over A Cancer Drug By Arpit Nayak September 11, 9:18 AM This story was first published on the Benzinga India portal. BMY
Read More 2 minute read Biotech General Health Care Media News Did Ozempic Play A Role In A Man’s Suicide? Family Seeks Warning Label By Benzinga Neuro September 11, 4:40 AM The family of a man who died by suicide is seeking a warning label on the ‘miracle’ weight… NONOF
Read More 2 minute read Equities General Health Care Markets News Walmart Contemplates Multi-billion Dollar Majority Stake In ChenMed By Nabaparna Bhattacharya September 9, 11:46 AM Walmart Inc. (NYSE: WMT) is reportedly contemplating the CVS
Read More 1 minute read Analyst Color Analyst Ratings Biotech General Health Care Initiation Movers News Penny Stocks Trading Ideas Microcap Firm ZyVersa Therapeutics Shows Promise Despite IPO Volatility, Analyst Initiates With Buy By Vandana Singh September 8, 2:52 PM HC Wainwright initiated coverage on ZyVersa Therapeutics Inc (NASDAQ: ZVSA) with a Buy Rating and a ZVSA
Read More 1 minute read Analyst Ratings Biotech General Health Care Initiation Movers News Penny Stocks Trading Ideas Breast Cancer-Focused Atossa Therapeutics Can Possibly Change Treatment Paradigm: Analyst By Vandana Singh September 8, 2:47 PM Cantor Fitzgerald has initiated coverage of Atossa Therapeutics Inc (NASDAQ: ATOS) with an Overweight rating and ATOS
Read More 1 minute read Analyst Ratings General Health Care Large Cap News Real Estate REIT Trading Ideas Upgrades Healthcare Focused REIT Omega Healthcare’s De-Risked Portfolio Attracts Investors Amidst Uncertain Environment By Vandana Singh September 8, 2:20 PM Mizuho Securities has upgraded Omega Healthcare Investors Inc (NYSE: OHI) from Neutral to Buy with a price target of $35, up from $31, citing optimistic industry and OHI
Read More 1 minute read Analyst Color Analyst Ratings Biotech Downgrades General Health Care Movers News Price Target Small Cap Trading Ideas Infectious Disease Player Vir Biotech Has Limited Near Term Upside, Analyst Downgrades By Vandana Singh September 8, 2:15 PM BofA Securities has downgraded Vir Biotechnology Inc (NASDAQ: VIR) to Neutral from Buy with a price target of $14, GILD
Read More 1 minute read Equities General Health Care Markets News Tech Palantir’s Power Move: Inks Pact With Policlinico Gemelli For AI-Driven Healthcare Solutions By Nabaparna Bhattacharya September 8, 11:40 AM Palantir Technologies Inc. (NYSE: PLTR) inked a pact with Fondazione Policlinico Universitario A. PLTR